BlueReg Group / Promotional & Advertising material review (drugs and medical devices)
As an outsourcing and consulting services company, BlueReg is your strategic partner to meet your goals for worldwide promotional material review and validation for drugs and medical devices. We provide a broad range of services linked to the review of promotional material for international congresses and local compliance. These flexible solutions range from an integrated package of services to adapted ad-hoc regulatory and technical support. Our goal is to explore innovative approaches and provide relevant advice to ensure you maintain your competitiveness in this complex and changing regulatory environment.
– Ensure a complete worldwide coordination with a project manager as your central contact point
– With our worldwide network of local partners, provide services of local signatories as per local requirements (e.g. ABPI signatory in the United Kingdom, Information Officer in Germany, Regulatory Scientific Services in Italy, Responsible Pharmacist in France…)
IFPMA code, WHO Resolution Ethical Criteria for Medicinal Drug Promotion, EFPIA code, Medical Device Regulation 2017/745 and local regulations such as ABPI code, ANSM recommendations, Medicines Australia Code of Conduct, ANVISA resolutions, Federal Food, Drug and Cosmetic Act ….
BlueReg has a team of experts with more than 20 years of experience who are dedicated to supporting your company’s promotional & advertising material activities for drugs and medical devices.
Our clients range from start-ups to global pharmaceutical companies, requiring a one-off, repetitive or permanent need for support with activities concerning promotional material review & validation.